Andrés Chang

974 total citations
22 papers, 630 citations indexed

About

Andrés Chang is a scholar working on Epidemiology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Andrés Chang has authored 22 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Andrés Chang's work include Respiratory viral infections research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (3 papers). Andrés Chang is often cited by papers focused on Respiratory viral infections research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (3 papers). Andrés Chang collaborates with scholars based in United States, Greece and Panama. Andrés Chang's co-authors include Rebecca Dutch, Cyril Masante, Ursula J. Buchholz, Everett Clinton Smith, Andreea Popa, Rachel M. Schowalter, Christopher R. Flowers, Jean L. Koff, Farah El Najjar and Carole L. Moncman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Andrés Chang

19 papers receiving 623 citations

Peers

Andrés Chang

EPIDE

IMMUN

GENET

Maya Braun Israel

Emily Burke United States

Lies Bogaert Belgium

Alessandra Coiana Italy

Astrid Meerbach Germany

Raphaële Germi France

Kirsten Kabsch Germany

Mireia Giménez‐Barcons Spain

Emmalene J. Bartlett United States

Yuzo Nagai Japan

Maya Braun Israel

Andrés Chang

363 ×0.8

EPIDE

432 ×1.6

100 ×1.3

61 ×0.8

IMMUN

44 ×0.7

GENET

Citations per year, relative to Andrés Chang Andrés Chang (= 1×) peers Maya Braun

Countries citing papers authored by Andrés Chang

Since Specialization

Citations

This map shows the geographic impact of Andrés Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrés Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrés Chang more than expected).

Fields of papers citing papers by Andrés Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrés Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrés Chang. The network helps show where Andrés Chang may publish in the future.

Co-authorship network of co-authors of Andrés Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Andrés Chang. A scholar is included among the top collaborators of Andrés Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrés Chang. Andrés Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Andrés, Donald J. McGuire, Amy Ayers, et al.. (2025). PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy. Proceedings of the National Academy of Sciences. 122(36). e2426935122–e2426935122.

Nayak, Rahul, et al.. (2024). Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy. Journal for ImmunoTherapy of Cancer. 12(10). e010116–e010116.

Chang, Andrés, Donald J. McGuire, Amy Ayers, et al.. (2024). PD-1 Expression Identifies Proliferating Chronic Lymphocytic Leukemia Cells and Informs Response and Resistance to BTK Inhibitor Therapy. Blood. 144(Supplement 1). 3235–3235. 1 indexed citations

Chang, Andrés, et al.. (2024). PANAMÁ EN TRANSICIÓN HACIA UN MODELO SOSTENIBLE: LA ECONOMÍA CIRCULAR COMO UNA ALTERNATIVA. 7(2). 73–86.

Cheedarla, Narayanaiah, Hans Verkerke, Shang‐Chuen Wu, et al.. (2023). Enhanced IgG immune response to COVID‐19 vaccination in patients with sickle cell disease. British Journal of Haematology. 202(5). 937–941. 5 indexed citations

Chang, Andrés, Jean L. Koff, Lilin Lai, et al.. (2023). Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies. Blood Advances. 7(11). 2459–2462. 7 indexed citations

Chang, Andrés, Anton M. Sholukh, Andreas Wieland, et al.. (2022). Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia. Journal of Clinical Investigation. 132(18). 4 indexed citations

Ayer, Turgay, et al.. (2021). Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma. Blood Cancer Journal. 11(1). 2–2. 27 indexed citations

Chang, Andrés, et al.. (2019). Human metapneumovirus fusion protein triggering: Increasing complexities by analysis of new HMPV fusion proteins. Virology. 531. 248–254. 6 indexed citations

10.

Chang, Andrés, Jackelyn B. Payne, Pamela B. Allen, et al.. (2019). Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(4). 239–243. 5 indexed citations

11.

Maier, Cheryl L., Satheesh Chonat, Andrés Chang, et al.. (2019). Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion. 59(5). 1698–1705. 17 indexed citations

12.

Harkins, R. Andrew, et al.. (2019). Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma. Expert Review of Hematology. 12(11). 959–973. 26 indexed citations

13.

Chang, Andrés, Tahseen H. Nasti, Mohammad K. Khan, et al.. (2018). Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma. Journal of Oncology Practice. 14(9). 561–564. 7 indexed citations

14.

Chang, Andrés, et al.. (2017). Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome. Expert Opinion on Investigational Drugs. 27(1). 55–70. 5 indexed citations

15.

Chang, Andrés, Cyril Masante, Ursula J. Buchholz, & Rebecca Dutch. (2012). Human Metapneumovirus (HMPV) Binding and Infection Are Mediated by Interactions between the HMPV Fusion Protein and Heparan Sulfate. Journal of Virology. 86(6). 3230–3243. 90 indexed citations

16.

Chang, Andrés, Brent A. Hackett, Christine Winter, Ursula J. Buchholz, & Rebecca Dutch. (2012). Potential Electrostatic Interactions in Multiple Regions Affect Human Metapneumovirus F-Mediated Membrane Fusion. Journal of Virology. 86(18). 9843–9853. 16 indexed citations

17.

Chang, Andrés & Rebecca Dutch. (2012). Paramyxovirus Fusion and Entry: Multiple Paths to a Common End. Viruses. 4(4). 613–636. 156 indexed citations

18.

Smith, Everett Clinton, Andreea Popa, Andrés Chang, Cyril Masante, & Rebecca Dutch. (2009). Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS Journal. 276(24). 7217–7227. 139 indexed citations

19.

Schowalter, Rachel M., et al.. (2008). Low-pH Triggering of Human Metapneumovirus Fusion: Essential Residues and Importance in Entry. Journal of Virology. 83(3). 1511–1522. 72 indexed citations

20.

McDonald, Sandra, et al.. (1992). Combined betaseron (recombinant human interferon beta) and radiation for inoperable nonsmall cell lung cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics. 24. 191–191. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact